Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion

Journal of Infectious Diseases

Volumn 205, Issue 5, 2012, Pages 763-771

  Raghuraman, Sukanya ^a   Park, Heiyoung ^a   Osburn, William O ^b   Winkelstein, Emily ^c   Edlin, Brian R ^c,d   Rehermann, Barbara ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c SUNY Downstate Medical Center   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYTOKINE; GAMMA INTERFERON; HEPATITIS C ANTIBODY; NEUTRALIZING ANTIBODY; PROGRAMMED DEATH 1 RECEPTOR; VIRUS RNA;

ACUTE PHASE RESPONSE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CELL COUNT; CELL SPECIFICITY; CELL STRESS; CELLULAR IMMUNITY; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; EPSTEIN BARR VIRUS; EVOLUTION; FEMALE; FOLLOW UP; GENE SEQUENCE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; HUMORAL IMMUNITY; IMMUNOASSAY; INFLAMMATION; INFLUENZA VIRUS; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SUPERINFECTION; T LYMPHOCYTE; VIRAL CLEARANCE; VIRUS CONCENTRATION;

ADOLESCENT; ADULT; ANTIBODIES, NEUTRALIZING; CYTOKINES; HEPACIVIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-GAMMA; LONGITUDINAL STUDIES; MALE; PROGRAMMED CELL DEATH 1 RECEPTOR; PROSPECTIVE STUDIES; RECOVERY OF FUNCTION; REMISSION, SPONTANEOUS; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES; VIRAL LOAD; YOUNG ADULT;

EID: 84863183220     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir835     Document Type: Article

References (49)

1. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45:529-38. (Pubitemid 44307383)
2. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001; 358: 958-65. (Pubitemid 32913521)
3. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347:975-82.
4. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006; 13:34-41.
5. Scott JD, McMahon BJ, Bruden D, et al. High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. Clin Infect Dis 2006; 42:945-52.
6. Watanabe H, Saito T, Shinzawa H, et al. Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study. J Med Virol 2003; 71:56-61. (Pubitemid 37121913)
7. Cacopardo B, Nunnari G, Nigro L. Clearance of HCV RNA following acute hepatitis A superinfection. Dig Liver Dis 2009; 41:371-4.
8. JessnerW, StrasserM, Graziadei I, Berr F, VogelW. Sustained remission of chronic hepatitis C after acute hepatitis B superinfection. Scand J Infect Dis 2006; 38:818-21. (Pubitemid 44304977)
9. Gruener NH, Jung MC, Ulsenheimer A, et al. Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response. J Hepatol 2002; 37:866-9. (Pubitemid 35404229)
10. Deterding K, Pothakamuri SV, Schlaphoff V, et al. Clearance of chronic HCV infection during acute delta hepatitis. Infection 2009; 37:159-62.
11. Suneetha PV, Mederacke I, Heim A, et al. Spontaneous clearance of chronic hepatitis C after liver transplantation: are hepatitis C virusspecific T cell responses the clue? Liver Transpl 2008; 14:1225-7.
12. Yoshikawa M, Morimoto Y, Shiroi A, Yoshiji H, Kuriyama S, Fukui H. Spontaneous elimination of serum HCV-RNA after total gastrectomy for early gastric cancer in a patient with chronic hepatitis C. Am J Gastroenterol 2001; 96:922-3. (Pubitemid 32240765)
13. Heller T, Rehermann B. Acute hepatitis C: a multifaceted disease. Semin Liver Dis 2005; 25:7-17. (Pubitemid 40322347)
14. Rehermann B. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J Clin Invest 2009; 119:1745-54.
15. Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med 2000; 6:578-82. (Pubitemid 30305910)
16. Wedemeyer H, He XS, Nascimbeni M, et al. Impaired effector function of hepatitis C virus-specific CD81 T cells in chronic hepatitis C virus infection. J Immunol 2002; 169:3447-58. (Pubitemid 35013196)
17. Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439: 682-7. (Pubitemid 43237609)
18. Rehermann B. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin Liver Dis 2007; 27:152-60. (Pubitemid 46871661)
19. Urbani S, Amadei B, Tola D, et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 2006; 80:11398-403. (Pubitemid 44706581)
20. Radziewicz H, Ibegbu CC, Fernandez ML, et al. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 2007; 81:2545-53. (Pubitemid 46447020)
21. Semmo N, Lucas M, Krashias G, Lauer G, Chapel H, Klenerman P. Maintenance of HCV-specific T-cell responses in antibody-deficient patients a decade after early therapy. Blood 2006; 107:4570-1. (Pubitemid 43801387)
22. Logvinoff C, Major ME, Oldach D, et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci USA 2004; 101:10149-54. (Pubitemid 38891210)
23. von Hahn T, Yoon JC, Alter H, et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology 2007; 132:667-78. (Pubitemid 46274668)
24. Edlin BR, Shu MA, Winkelstein E, et al. More rare birds, and the occasional swan. Gastroenterology 2009; 136:2412-4.
25. Veerapu NS, Raghuraman S, Liang TJ, Heller T, Rehermann B. Sporadic reappearance of minute amounts of hepatitis C virus RNA after successful therapy stimulates cellular immune responses. Gastroenterology 2011; 140:676-85 e1.
26. Liu Z, Netski DM, Mao Q, et al. Accurate representation of the hepatitis C virus quasispecies in 5.2-kilobase amplicons. J Clin Microbiol 2004; 42:4223-9. (Pubitemid 39296148)
27. Yi M, Ma Y, Yates J, Lemon SM. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. J Virol 2007; 81:629-38. (Pubitemid 46067890)
28. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005; 11:791-6. (Pubitemid 41021213)
29. Lindenbach BD, Evans MJ, Syder AJ, et al. Complete replication of hepatitis C virus in cell culture. Science 2005; 309:623-6. (Pubitemid 41033648)
30. Lindenbach BD. Measuring HCV infectivity produced in cell culture and in vivo. Methods Mol Biol 2009; 510:329-36.
31. Dowd KA, Netski DM, Wang XH, Cox AL, Ray SC. Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. Gastroenterology 2009; 136:2377-86.
32. Hsu M, Zhang J, Flint M, et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA 2003; 100:7271-6. (Pubitemid 36706428)
33. Lechner F, Gruener NH, Urbani S, et al. CD81 T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 2000; 30:2479-87.
34. McMahan RH, Golden-Mason L, NishimuraMI, et al. Tim-3 expression on PD-11 HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 2010; 120:4546-57.
35. Bengsch B, Spangenberg HC, Kersting N, et al. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD81 T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J Virol 2007; 81:945-53. (Pubitemid 46067919)
36. Nakamoto N, Kaplan DE, Coleclough J, et al. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 2008; 134: 1927-37, 1937 e1-2.
37. Bengsch B, Seigel B, Ruhl M, et al. Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD81 T cells is linked to antigen recognition and T cell differentiation. PLoS Pathog 2010; 6: e1000947.
38. Said EA, Dupuy FP, Trautmann L, et al. Programmed death-1-induced interleukin-10 production by monocytes impairs CD41 T cell activation during HIV infection. Nat Med 2010; 16:452-9.
39. Kasprowicz V, Schulze Zur Wiesch J, Kuntzen T, et al. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD81 and CD41 T cells during acute HCV infection, irrespective of clinical outcome. J Virol 2008; 82:3154-60. (Pubitemid 351329205)
40. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443:350-4. (Pubitemid 44435155)
41. Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med 2001; 194:1395-406. (Pubitemid 33081515)
42. Rahman F, Heller T, Sobao Y, et al. Effects of antiviral therapy on the cellular immune response in acute hepatitis C. Hepatology 2004; 40:87-97. (Pubitemid 38868927)
43. Lauer GM, Lucas M, Timm J, et al. Full-breadth analysis of CD81 T-cell responses in acute hepatitis C virus infection and early therapy. J Virol 2005; 79:12979-88. (Pubitemid 41433217)
44. Boni C, Bertoletti A, Penna A, et al. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998; 102:968-75. (Pubitemid 28419565)
45. Boni C, Penna A, Ogg GS, et al. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001; 33:963-71. (Pubitemid 32246646)
46. Wherry EJ, Blattman JN, Ahmed R. Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination. J Virol 2005; 79:8960-8. (Pubitemid 40934807)
47. Wedemeyer H, Mizukoshi E, Davis AR, et al. Cross-reactivity between hepatitis C virus and Influenza A virus determinant-specific cytotoxic T cells. J Virol 2001; 75:11392-400. (Pubitemid 33063230)
48. Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol 2002; 2:417-26. (Pubitemid 37328749)
49. Ciesek S, Manns MP. Hepatitis in 2010: the dawn of a new era in HCV therapy. Nat Rev Gastroenterol Hepatol 2011; 8:69-71.